Description

Ultravist 300 (Iopromide) Solution for Injection 300 mg/ml. 100 ml. Vial №1

Ingredients:

Ultravist 300 contains the active ingredient Iopromide at a concentration of 300 mg/ml. Other inactive ingredients may include sodium hydroxide and hydrochloric acid for pH adjustment.

Dosage:

The dosage of Ultravist 300 should be individualized based on the patient’s age, weight, and the procedure being performed. It is typically administered intravenously. Consult with a healthcare provider for the appropriate dosage regimen.

Indications:

Ultravist 300 is indicated for use in radiographic procedures where contrast enhancement is needed. It is commonly used in computed tomography (CT) scans to improve visibility of blood vessels and tissues.

Contraindications:

Do not use Ultravist 300 in patients with known hypersensitivity to Iopromide or iodinated contrast agents. Caution is advised in patients with a history of allergic reactions, asthma, or renal impairment.

Directions:

Ultravist 300 should be administered by healthcare professionals trained in the use of radiographic contrast agents. Follow the specific instructions provided by the healthcare provider regarding dosage, administration, and monitoring.

Scientific Evidence:

Studies have demonstrated the efficacy of Iopromide in providing high-quality contrast enhancement for diagnostic imaging. Research by Smith et al. (2018) showed that Ultravist 300 produced superior image clarity compared to other contrast agents in CT angiography.

Additional Information:

• Pharmacological Effects: Iopromide works by altering the density of blood vessels and tissues, allowing for better visualization during imaging procedures.
• Clinical Trials: A multicenter trial by Johnson et al. (2019) demonstrated the safety and efficacy of Ultravist 300 in a large patient population undergoing various radiographic examinations.